|Bid||0.00 x N/A|
|Ask||0.00 x N/A|
|Day's Range||43.20 - 43.20|
|52 Week Range||34.80 - 54.50|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Earnings Date||Feb 22, 2023|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Subscribe to Yahoo Finance Plus to view Fair Value for NK8.MU
NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced today the Company will release its fourth quarter and full-year 2022 results on Wednesday, February 22, 2023, after the close of the market.
NuVasive, Inc. ( NASDAQ:NUVA ) shareholders should be happy to see the share price up 10% in the last quarter. But that...
NuVasive (NUVA) believes that its 2022 guidance is appropriately conservative, considering macroeconomic pressures on net sales and operating profit.